The proof-of-concept study, co-led by McGill University researchers Dr. Matthew Dankner and Dr. Reza Forghani, alongside an international team of clinicians and scientists, demonstrated the AI model can detect the presence of cancer cells in surrounding brain tissue with 85-per-cent accuracy.
Knowing who may progress along the disease pathway is critical for early diagnosis and intervention, improved treatment and better disease management,
The artificial intelligence–based model, dubbed SCORPIO, was developed by a team of researchers from Memorial Sloan Kettering Cancer Center (MSK) and the Tisch Cancer Institute at Mount Sinai.